ImmunoGen Leverages High Stock Price with $84M Offering
By Trista Morrison
Monday, May 23, 2011
Despite having a healthy amount of cash in its coffers, ImmunoGen Inc. capitalized on the fact that its stock is heading toward a 10-year high and raised $84 million in a public offering.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.